GERON CORP
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
GERN$0.97-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||
| Common Stock · Paid-In · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Amount | Capital | Deficit | Income (Loss) | Equity | |
| (In thousands, except share data) | ||||||
| Balances at December 31, 2022 | 390,262,524 | $390 | $1,493,469 | $(1,413,642) | $(219) | 79,998 |
| Net loss | — | — | — | (184,127) | — | (184,127) |
| Other comprehensive income (loss) | — | — | — | — | 431 | 431 |
| Foreign currency translation adjustment | — | — | — | — | (27) | (27) |
| Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs of $14,507 | 68,007,741 | 68 | 213,269 | — | — | 213,337 |
| Issuance of common stock in connection with exercise of warrants | 77,349,858 | 78 | 105,834 | — | — | 105,912 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 36,864 | 1 | 828 | — | — | 829 |
| Issuances of common stock under equity plans | 9,255,228 | 8 | 13,062 | — | — | 13,070 |
| Stock-based compensation for equity-based awards to employees and directors | — | — | 18,526 | — | — | 18,526 |
| Balances at December 31, 2023 | 544,912,215 | 545 | 1,844,988 | (1,597,769) | 185 | 247,949 |
| Net loss | — | — | — | (174,572) | — | (174,572) |
| Other comprehensive income (loss) | — | — | — | — | 88 | 88 |
| Foreign currency translation adjustment | — | — | — | — | (12) | (12) |
| Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs of $9,271 | 41,999,998 | 42 | 140,687 | — | — | 140,729 |
| Issuance of common stock in connection with exercise of warrants | 1,071,981 | 1 | 1,393 | — | — | 1,394 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 8,351 | — | 134 | — | — | 134 |
| Issuances of common stock under equity plans | 18,395,121 | 18 | 32,665 | — | — | 32,683 |
| Stock-based compensation for equity-based awards to employees and directors | — | — | 31,927 | — | — | 31,927 |
| Balances at December 31, 2024 | 606,387,666 | 606 | 2,051,794 | (1,772,341) | 261 | 280,320 |
| Net loss | — | — | — | (83,500) | — | (83,500) |
| Other comprehensive income (loss) | — | — | — | — | (45) | (45) |
| Foreign currency translation adjustment | — | — | — | — | 53 | 53 |
| Issuance of common stock in connection with exercise of warrants | 30,369,830 | 31 | 1,510 | — | — | 1,541 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 22,073 | — | 88 | — | — | 88 |
| Subscription receivables | 1,162,376 | — | (1,511) | — | — | (1,511) |
| Issuances of common stock under equity plans | 1,275,292 | 2 | 1,518 | — | — | 1,520 |
| Stock-based compensation for equity-based awards to employees and directors | — | — | 26,659 | — | — | 26,659 |
| Issuances of common stock under employee stock purchase plan | 638,985 | 1 | 746 | — | — | 747 |
| Balances at December 31, 2025 | 639,856,222 | $640 | $2,080,804 | $(1,855,841) | $269 | $225,872 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.